Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosisWeerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, 11000, Thailand
Clin Infect Dis 44:141-4. 2007
..047), but no nevirapine-related adverse events occurred. There was no statistically significant difference in 60-week antiviral efficacy between these patients and patients receiving nevirapine-based antiretroviral therapy alone (P>.05)...
- Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/microL
Weerawat Manosuthi
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Tiwanon Road, Nonthaburi 11000, Thailand
Int J STD AIDS 18:782-6. 2007
..Despite the low baseline in this population, the higher number of baseline CD4 cells is continuously associated with a higher risk for skin rashes...
A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R StudyWeerawat Manosuthi
Dept of Medicine, Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Tiwanon Rd, Nonthaburi 11000, Thailand
Clin Infect Dis 48:1752-9. 2009
....
- Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting
Weerawat Manosuthi
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand
Int J Infect Dis 12:582-6. 2008
..To determine the mortality rate and risk factors after experiencing symptomatic hyperlactatemia in HIV-infected patients receiving antiretroviral therapy (ART)...
- Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi and Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
J Acquir Immune Defic Syndr 43:42-6. 2006
..The impact of antiretroviral therapy (ART) on survival among patients coinfected with HIV and tuberculosis (TB) has not been well established...
- Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
J Med Assoc Thai 91:159-65. 2008
..To determine incidence and risk factors of nevirapine (NVP)-associated severe hepatitis that led to NVP discontinuation among HIV-infected patients with CD4 < 250 cells/microL...
- Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, 11000, Thailand
Clin Infect Dis 43:253-5. 2006
..Mean plasma nevirapine levels at 8 and 12 weeks were lower in patients receiving rifampicin (P=.048). However, virological and immunological outcomes at 24 weeks were not different between the 2 groups (P>.05)...
- Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy
Weerawat Manosuthi
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Tiwanon Road, Nonthaburi 11000, Thailand
J Infect 53:357-63. 2006
..To determine the frequency, risk factors and mortality rate of immune reconstitution inflammatory syndrome (IRIS) of tuberculosis (TB) in patients co-infected with HIV/TB and receiving antiretroviral therapy (ART)...
- Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi 11000, Thailand
J Infect 55:464-9. 2007
..To study incidence, risk factors, and impact of major opportunistic infections (OIs) after initiation of antiretroviral therapy (ART)...
Durability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients with/without prior co-administration of rifampicin: a 144-week prospective studyWeerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, 11000, Thailand
BMC Infect Dis 8:136. 2008
..To date, data on the durability of a regimen of stavudine, lamivudine and nevirapine are very limited, particularly from the resource-limited settings...
- Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis
Weerawat Manosuthi
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Tiwanon Road, Nonthaburi 11000, Thailand
Int J STD AIDS 19:268-71. 2008
..In resource-limited settings, the use of temporary external lumbar drainage is a safe and effective management strategy for intractable elevated ICP in HIV-infected patients with cryptococcal meningitis...
- Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin
W Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
HIV Med 9:294-9. 2008
..There is limited comparative data between efavirenz (EFV) 600 mg/day and nevirapine (NVP) 400 mg/day-based antiretroviral therapy (ART) among HIV-1 patients with tuberculosis (TB) and receiving rifampicin...
- Evaluating the role of etravirine in the second-line antiretroviral therapy after failing an initial non-nucleoside reverse transcriptase inhibitor-based regimen in a resource-limited setting
Somnuek Sungkanuparph
Department of Medicine, Ministry of Public Health, Nonthaburi, Thailand
Curr HIV Res 6:474-6. 2008
..This strategy may be an option for patients who cannot afford or tolerate protease inhibitor. Prospective study to evaluate this strategy should be conducted in resource-limited setting...
- Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results
Weerawat Manosuthi
Bamrasnaradura Institute, Ministry of Public Health, Nonthaburi, Thailand
AIDS 20:131-2. 2006
..We report the similar virological and immunological outcomes at 48 weeks between the two groups. Efavirenz 600 mg/day should be sufficient for concurrent use with rifamipicin...
- Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin
Weerawat Manosuthi
Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
AIDS 19:1481-6. 2005
..Concomitant use of efavirenz and rifampicin is common for treatment of HIV and tuberculosis. Plasma efavirenz levels can be reduced by rifampicin, but the appropriate daily dosage of efavirenz is unclear...
- Influence of ABCB-1 C3435T polymorphisms on plasma nevirapine and efavirenz levels and their effects on virologic and immunological outcomes in HIV/TB co-infected Thai adults under anti-retroviral therapy
Sumonmal Uttayamakul
Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Southeast Asian J Trop Med Public Health 43:78-88. 2012
....
- Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting
Krittaecho Siripassorn
Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
AIDS Res Hum Retroviruses 26:139-48. 2010
..In the subgroup analysis, patients who received double-boosted PIs demonstrated a superior immunological response but not better virological outcomes compared to the single-boosted PI +/- OBR group...
- Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine
Somnuek Sungkanuparph
Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama 6 Road, Bangkok 10400, Thailand
J Clin Virol 41:310-3. 2008
..K65R mutations that occur after failing this regimen prevent the use of tenofovir, didanosine, and abcavir in the second-line regimen...
- Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin
Weerawat Manosuthi
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi 11000, Thailand
Antimicrob Agents Chemother 53:4545-8. 2009
..5 +/- 2.7 mg/liter, respectively. High body weight was associated with a low efavirenz C12 at weeks 6 and 12 (P = 0.003, r = -0.255). The efavirenz C12 regression prediction line at 1 mg/liter intercepted a mean body weight of 57.5 kg...
- Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study
Weerawat Manosuthi
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
J Acquir Immune Defic Syndr 60:377-83. 2012
..Optimal timing for initiation of antiretroviral therapy (ART) among HIV-infected patients with tuberculosis (TB) is not well established...
- Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study
Weerawat Manosuthi
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Tiwanon Road, Nonthaburi 11000, Thailand
Int J Infect Dis 14:e1013-7. 2010
..Long-term outcomes of this concurrent treatment are unknown...
- Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails
Somnuek Sungkanuparph
Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Clin Infect Dis 44:447-52. 2007
..Virological failure with this regimen has become more common, and a second-line regimen needs to be prepared in the national program...
- Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy
Pawinee Wongprasit
Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
AIDS Patient Care STDS 24:205-9. 2010
..Positive HBeAg and longer duration of lamivudine use are risk factors for HBV-DR. In addition to lamivudine resistance, cross-resistance to other anti-HBV drugs is also frequently observed...
- Tenofovir resistance among HIV-infected patients failing a fixed-dose combination of stavudine, lamivudine, and nevirapine in a resource-limited setting
Somnuek Sungkanuparph
Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
AIDS Patient Care STDS 21:711-4. 2007
- Virological and immunological responses of efavirenz-based HAART regimen initiated in HIV-infected patients at CD4 < 100 versus CD4 > or = 100 cells/mm3
Sasisopin Kiertiburanakul
Division of lnfectious Diseases, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
J Med Assoc Thai 89:1381-7. 2006
..232). The adverse events were similar between the two groups. CONCLUSION: Initiation of EFV-based HAART regimen in HIV-infected patients at CD4 < 100 and > or = 100 cells/ mm3 gains similar immunological and virological response...
- Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study
Weerawat Manosuthi
Bamrasnaradura Institute, Ministry of Public Health, Nonthaburi, 11000, Thailand
BMC Infect Dis 5:67. 2005
..To compare the adverse events after initiation of NVP-based ART among HIV-infected patients who did not receive fluconazole (group A), received fluconazole 400 mg/week (group B), and received fluconazole 200 mg/day (group C)...
- Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi
J Med Assoc Thai 90:244-50. 2007
..A fixed-dose combination of stavudine, lamivudine, and nevirapine (GPO-VIR) is the most affordable antiretroviral therapy (ART) regimen in Thailand. The data of nevirapine (NVP) level and efficacy of this fixed-dose combination is limited...
- Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
BMC Infect Dis 7:14. 2007
..The clinical data of plasma NVP level, safety and efficacy of antiretroviral therapy (ART) for the concurrent use of nevirapine (NVP)-based ART and fluconazole (FLU) is scanty...
- Tipranavir resistance associated mutations in protease inhibitor-naïve patients with HIV-1 subtype A/E infection
Somnuek Sungkanuparph
Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
J Clin Virol 43:284-6. 2008
..Tipranavir-resistance associated mutations (TPV-RAMs) are often observed among patients with HIV-1 subtype A/E infection. Data regarding TPV resistance in subtype A/E is still limited...
- Initiation of highly active antiretroviral therapy in advanced AIDS with CD4 < 50 cells/mm3 in a resource-limited setting: efficacy and tolerability
Somnuek Sungkanuparph
Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
Int J STD AIDS 16:243-6. 2005
..Twenty two patients (13.8%) had adverse drug events and half of these had to discontinue HAART. Initiation of HAART in advanced AIDS with CD4 cell count < 50 cells/mm3 is effective, safe, and well tolerated and should not be delayed...
- Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy
Somnuek Sungkanuparph
Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Rama 6 Rd, Bangkok 10400, Thailand
J Med Assoc Thai 90:884-8. 2007
..Antiretroviral therapy (ART) has been more accessible in these countries. The present study aimed to determine the impact of ART on the prevalence of DR-TB among HIV/TB co-infected patients...
- Lipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapy
Wiroj Mankhatitham
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
J Med Assoc Thai 95:163-9. 2012
..To study and compare the pattern of lipid profile changes in Thai HIV and tuberculosis (TB) co-infected patients after receiving two non-nucleoside reverse transcriptase inhibitors (NNRTIs)-based antiretroviral therapy (ART)...
- Successful viral suppression with subsequent efavirenz-based regimen in HIV-1-infected patients who stop nevirapine prior to discontinuation of the NRTI backbone
Sukanya Chimsuntorn
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Tiwanon Road, Nonthaburi, Thailand
J Int Assoc Physicians AIDS Care (Chic) 9:43-5. 2010
....
- Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen
Wiroj Mankhatitham
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
Southeast Asian J Trop Med Public Health 42:651-8. 2011
..03; 95%CI 1.26-7.29) was an independent risk factor associated with grade 1-4 hepatotoxicity (p=0.013). Monitoring of hepatotoxicity should be considered in TB/HIV-1 co-infected patients who are infected with HCV and receiving NVP...
- Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
Southeast Asian J Trop Med Public Health 42:643-50. 2011
..This report highlights the potentially irreversible adverse effect of this agent, particularly in patients with vulnerable kidneys and concomitant use of tenofovir and boosted PI...
- Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008
Somnuek Sungkanuparph
Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand
J Med Assoc Thai 91:1925-35. 2008
....
- Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis
Weerawat Manosuthi
Bamrasnaradura Institute, Ministry of Public Health, Nonthaburi, Thailand
J Med Assoc Thai 89:795-802. 2006
..neoformans) obtained from the CerebroSpinal Fluid (CSF); and clinical outcomes of HIV-infected patients diagnosed with cryptococcal meningitis...
- Survival time of HIV-infected patients with cryptococcal meningitis
Suthat Chottanapund
Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
J Med Assoc Thai 90:2104-11. 2007
..To study survival time and risk factors of mortality among HIV-infected patients who had cryptococcal meningitis...
- Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Thailand
Antimicrob Agents Chemother 57:1019-24. 2013
..084, P = 0.027) and high body weight (beta = -0.076, P = 0.002). In conclusion, pharmacogenetic markers of CYP2B6 have the greatest impact with respect to inducing low plasma efavirenz concentrations in HIV/TB Thai patients...
- Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting
Somnuek Sungkanuparph
Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Southeast Asian J Trop Med Public Health 39:863-6. 2008
..8% had HCV infection. Given the relatively high prevalence of HBV and HCV infection among HIV-infected patients, screening for HBV and HCV infections prior to ART initiation should not be omitted in the resource-limited setting...
- Clinical characteristics and treatment outcomes among patients with tuberculosis in Bangkok and Nonthaburi, Thailand
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
Southeast Asian J Trop Med Public Health 43:1426-36. 2012
..The percent of patients with unfavorable outcomes was relatively high, particularly among HIV co-infected and elderly subjects. Further effort needs to be made to improve these unfavorable TB outcomes in Nonthaburi and Bangkok, Thailand...
- Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
AIDS 23:2467-71. 2009
..The performance of this definition and clinical manifestations of TB-IRIS were studied...
- Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study
Somnuek Sungkanuparph
Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
J Med Assoc Thai 87:1349-54. 2004
..Information regarding prevalence of HBV and HCV co-infection with HIV in Thailand is limited...
- Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
AIDS Res Ther 7:37. 2010
..However, knowledge regarding whether there is any difference of the frequency of renal injury between tenofovir/lamivudine/efavirenz and tenofovir/lamivudine/nevirapine is lacking...
- Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, 11000, Thailand
AIDS Res Ther 6:30. 2009
....
- Chronic neck ulcer in an immunocompetent host
Weerawat Manosuthi
Department of Medicine, Ramathibodi Hospital, Mahidol University, 270 Rama 6 Road, Bangkok 10400, Thailand
Lancet Infect Dis 5:190. 2005
- HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection
Weerawat Manosuthi
Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand
J Med Virol 85:194-9. 2013
..HIV-1 DRAMs, especially to NNRTIs, are emerging in a middle-income country after widespread use of NNRTI-based ART. HIV genotypic assays before ART initiation in patients with chronic HIV-1 infection should be considered...
- Health related quality of life among patients with tuberculosis and HIV in Thailand
Wanitchaya Kittikraisak
Thailand Ministry of Public Health, U S Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
PLoS ONE 7:e29775. 2012
..Health utilities of tuberculosis (TB) patients may be diminished by side effects from medication, prolonged treatment duration, physical effects of the disease itself, and social stigma attached to the disease...
- Single-Boosted Protease Inhibitor versus Double-Boosted Protease Inhibitors for the Salvage Therapy in HIV-Infected Patients
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi, Thailand, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
J Int Assoc Physicians AIDS Care (Chic) 10:105-10. 2011
....
- Virological failure of staggered and simultaneous treatment interruption in HIV patients who began Efavirenz-based regimens after allergic reactions to nevirapine
Krittaecho Siripassorn
Department of Internal Medicine, Bamrasnaradura Infectious Diseases Institute, 126 Tiwanon Road, Nonthaburi, 11000, Thailand
AIDS Res Ther 10:4. 2013
..abstract:..
- Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure
Weerawat Manosuthi
Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health, Nonthaburi 11000, Thailand
AIDS Res Ther 9:8. 2012
..abstract:..
- Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults
Sumonmal Uttayamakul
Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
AIDS Res Ther 7:8. 2010
..CONCLUSIONS: CYP2B6-TT genotype had impact on plasma efavirenz and nevirapine concentrations, while rifampicin co-administration had only small effects...
- Case report: Brucellosis: a re-emerging disease in Thailand
Weerawat Manosuthi
Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Bangkok, Thailand
Southeast Asian J Trop Med Public Health 35:109-12. 2004
..This clinical syndrome should be included in the differential diagnosis of patients presenting with prolonged fever, particularly those with contact to animals which could serve as reservoirs...
- Concurrent chromomycosis and aspergillosis of the maxillary sinus
Weerawat Manosuthi
Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand
J Med Assoc Thai 87:1112-5. 2004
..The patient responded to a combination therapy of surgical excision and antifungal agent...
- Clinical experience with high success rate of antiretroviral therapy in elderly HIV-infected patients
Somnuek Sungkanuparph
Age Ageing 33:520-1. 2004
- Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir
Weerawat Manosuthi
J Acquir Immune Defic Syndr 47:127-9. 2008
- Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin
Anchalee Avihingsanon
HIV NAT, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
Antivir Ther 13:529-36. 2008
..We aim here to determine the appropriate dose of nevirapine (NVP) in Thai HIV-tuberculosis (TB)-coinfected patients receiving rifampicin...
- Mortality rate of early versus deferred initiation of antiretroviral therapy in HIV-1-infected patients with cryptococcal meningitis
Weerawat Manosuthi
J Acquir Immune Defic Syndr 48:508-9. 2008
